CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation of $9.30 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation · last filed 2017-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2016 was $9.30M, a 12.26% decline from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2015 was $10.60M, a 146.51% increase from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2014 was $4.30M, a 290.91% increase from fiscal 2013.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for fiscal 2013 was $1.10M.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 12 month as first filed |
|---|---|---|
| 2016-12-31 | $9.30M 10-K · filed 2017-02-14 | |
| 2015-12-26 | $10.60M 10-K · filed 2017-02-14 | |
| 2014-12-27 | $4.30M 10-K · filed 2016-02-12 | |
| 2013-12-28 | $1.10M 10-K · filed 2015-02-17 | -$1.07M 10-K · filed 2014-02-25 |
| 2012-12-29 | -$125.00K 10-K · filed 2013-02-27 | |
| 2011-12-31 | $802.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |